Purification of 5-hydroxytryptamine(3) receptors from porcine brain

被引:20
作者
Fletcher, S
Barnes, NM
机构
[1] Department of Pharmacology, Medical School, University of Birmingham, Edgbaston
关键词
5-hydroxytryptamine; 5-HT3; receptor; solubilization; purification; pig brain; receptor subunits;
D O I
10.1038/sj.bjp.0701439
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We demonstrate, for the first time, the purification of the 5-hydroxytryptamine, (5-HT3) receptor from a native tissue source, pig cerebral cortex. 2 From a range of detergents, the non-ionic detergent Triton X-100 was demonstrated to exhibit the least inhibition of [H-3]-(S)-zacopride binding to membrane bound 5-HT3 receptors from pig cerebral cortex at concentrations above its critical micellular concentration (CMC). This detergent was therefore selected to solubilize 5-HT3 binding sites from homogenates of pig cerebral cortex. Maximum yield (43.8+/-3.7%, mean+/-s.e.mean, n=13) was obtained with Triton X-100 at 0.4% (22.1xCMC). Radioligand binding studies with [H-3]-(S)-zacopride indicated that the solubilized 5-HT3 receptor displayed near identical pharmacology to the membrane bound receptor (the correlation coefficient (r) between the pK(i) values of structurally unrelated compounds competing for [H-3]-(S)-zacopride binding in the membrane bound and solubilized 5-HT3 receptor preparations was 0.99, B-max=20.7+/-4.2 fmol mg(-1) protein, K-d=1.57+/-0.53 nM, mean+/-s.e.mean, n=6). 3 Solubilized (0.4% Triton X-100) 5-HT3 receptors were affinity purified using Affi-Gel 15 coupled to the high affinity 5-HT3 receptor ligand GR119566X. Radioligand binding studies indicated that the pharmacological profile of the affinity purified 5-HT3 receptor, assessed using ligands with a range of affinities spanning 3 orders of magnitude, was similar to that in both crude homogenates (r=0.85) and solubilized 5-HT3 receptor sites (r=0.65) from pig brain. The specific activity for the purified 5-HT3 receptor overlapped the theoretical specific activity of the receptor (B-max=3.27+/-1.41 and 5.35+/-2.33 nmol mg(-1) protein, assessed by saturation and competition studies respectively, mean+/-s.e.mean, n=3-4), which indicated a 60 000-100 000 fold purification of the membrane bound receptor. 4 Under non-reducing conditions, samples of the affinity purified protein failed to enter a 10% separating gel in SDS-PAGE analysis, indicating a molecular mass for the receptor complex of >200 kDa. Further investigation of the non-reduced purified protein with a 7.5% separating gel gave a mass for the complex of similar to 279 kDa. Under reducing conditions, SDS-PAGE analysis of the affinity purified 5-HT3 receptor resulted in 3-6 silver stained bands at apparent molecular masses of 37, 44-50 52, 57-61, 63 and 65-71 kDa (n=12). Unlike protein bands at 45, 50, 60 and 66 kDa, the bands corresponding to proteins of 52, 57, 63 and 71 kDa consistently gave no reaction with an antiserum specific for the cloned A subunit of the 5-HT3 receptor in both a modified dot blot procedure and a Western blot procedure (n=2-5). 5 We conclude that we have purified the 5-HT3 receptor from pig brain to homogeneity and suggest this may contain non-5-HT3-A receptor subunit(s).
引用
收藏
页码:655 / 662
页数:8
相关论文
共 41 条
[31]  
MCKERNAN RM, 1990, J BIOL CHEM, V265, P13572
[32]  
MIYAKE A, 1995, MOL PHARMACOL, V48, P407
[33]   Cellular and subcellular immunolocalization of the type 3 serotonin receptor in the rat central nervous system [J].
Morales, M ;
Battenberg, E ;
deLecea, L ;
Sanna, PP ;
Bloom, FE .
MOLECULAR BRAIN RESEARCH, 1996, 36 (02) :251-260
[34]  
Mukerji J, 1996, J NEUROCHEM, V66, P1027
[35]  
NEUGEBAUER J, 1992, GUIDE PROPERTIES USE
[36]  
PERREN MJ, 1995, N-S ARCH PHARMACOL, V351, P221
[37]   RECENT ADVANCES IN THE ELECTROPHYSIOLOGICAL CHARACTERIZATION OF 5-HT3 RECEPTORS [J].
PETERS, JA ;
MALONE, HM ;
LAMBERT, JJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (10) :391-397
[38]   ACH RECEPTOR RICH MEMBRANE DOMAINS ORGANIZED IN FIBROBLASTS BY RECOMBINANT 43-KILDALTON PROTEIN [J].
PHILLIPS, WD ;
KOPTA, C ;
BLOUNT, P ;
GARDNER, PD ;
STEINBACH, JH ;
MERLIE, JP .
SCIENCE, 1991, 251 (4993) :568-570
[40]  
Turton S., 1993, Molecular Neuropharmacology, V3, P167